| Division of Bioengineering and Physical Science
Transferred to the National Institute of Biomedical Imaging and
Bioengineering
The National Institute of Biomedical Imaging and Bioengineering
(NIBIB) today announced the integration of the Division of Bioengineering
and Physical Science (DBEPS), formerly part of the NIH Office of
Research Services, into the NIBIB Intramural Research Program.
The expertise of the DBEPS staff supports the mission of the NIBIB
to integrate bioengineering with the life and physical sciences,
and spans cutting-edge technologies operating at scales ranging
from near-atomic resolution to intact organisms.
"We are excited about the transfer of this exceptional cadre of
researchers to the NIBIB Intramural Research Program," said NIBIB
Director Roderic I. Pettigrew, Ph.D., M.D. "The unique expertise
and cutting-edge technologies developed by this group are an exceptional
fit with the mission of the institute, which is to improve health
by leading the development and accelerating the application of
biomedical technologies."
The Laboratory of Bioengineering and Physical Science specializes
in the development and application of new technologies, based on
engineering, mathematics, and the physical sciences, for the solution
of problems in biology and medicine. The 26 staff members formerly
associated with DBEPS have been transferred to NIBIB, along with
equipment and over 14,000 square feet of laboratory space. The
current laboratory structure will be maintained, and staff will
perform their same functions.
Consultations and collaborative research with other NIH intramural
scientists will continue to be the main focus of this group's work.
Research areas currently include new approaches to determine three-dimensional
cellular structure, measuring interactions between macromolecules,
modeling drug delivery, and performing nanoscale diagnostics.
"I look forward to increasing the impact of the DBEPS program
through the innovative and stimulating environment of NIBIB, and
to enhancing our collaborative contributions to the research programs
of all the other NIH institutes and centers," said NIBIB Scientific
Director Richard D. Leapman, Ph.D. "Incorporation of DBEPS into
NIBIB will also provide an ideal setting for the new trans-NIH
initiative in Imaging Molecules to Cells, which we will
be helping to lead."
In addition to the added staff and laboratory space, the transfer
brings to the NIBIB Intramural Research Program some unique training
opportunities for undergraduate biomedical engineering students
and postdoctoral scientists and engineers through the Biomedical
Engineering Summer Internship Program (http://www.nibib.nih.gov/Training/UndergradGrad/besip/home),
and the National Research Council NIH/NIST Research Associateship
Program (http://www.training.nih.gov/postdoctoral/nist.asp).
This new intramural component will join the existing NIBIB Intramural
Research Program, which includes the PET Radiochemistry Research
Laboratory responsible for conducting research and training in
the development and application of novel radiochemical probes for
biomedical imaging, and the joint Laboratory for the Assessment
of Medical Imaging Systems at the FDA.
The National Institute of Biomedical Imaging and Bioengineering
(NIBIB), a component of the National Institutes of Health, U.S.
Department of Health and Human Services, is dedicated to improving
human health through the integration of the physical and biological
sciences. The research agenda of the NIBIB will dramatically advance
the Nation's health by improving the detection, management, understanding,
and ultimately, the prevention of disease. Additional information
and publications are available at www.nibib.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.
|